Skip to main content

Psychiatric Aspects of Wilson Disease

  • Chapter
  • First Online:
Management of Wilson Disease

Part of the book series: Clinical Gastroenterology ((CG))

  • 493 Accesses

Abstract

Psychiatric disturbances represent an important diagnostic and therapeutic issue in Wilson disease (WD). They represent a significant part of the clinical presentation of WD and can present at any point in the course of the illness. In this chapter, we are going to discuss relevant aspects of the clinical evaluation of psychiatric symptoms in WD, prevalence of psychiatric symptoms, significance of psychiatric symptoms, and treatment considerations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Bibliography

  1. Wilson SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain. 1912;34(4):295–507.

    Article  Google Scholar 

  2. Bornstein RA, McLean DR, Ho K. Neuropsychological and electrophysiological examination of a patient with Wilson disease. Int J Neurosci. 1985;26(3–4):239–47.

    Article  CAS  PubMed  Google Scholar 

  3. Seniow J, Bak T, Gajda J, Poniatowska R, Czlonkowska A. Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson disease. Mov Disord. 2002;17(5):1077–83.

    Article  PubMed  Google Scholar 

  4. Portala K, Levander S, Westermark K, Ekselius L, von Knorring L. Pattern of neuropsychological deficits in patients with treated Wilson disease. Eur Arch Psychiatry Clin Neurosci. 2001;251(6):262–8.

    Article  CAS  PubMed  Google Scholar 

  5. Rosselli M, Lorenzana P, Rosselli A, Vergara I. Wilson disease, a reversible dementia: case report. J Clin Exp Neuropsychol. 1987;9(4):399–406.

    Article  CAS  PubMed  Google Scholar 

  6. Rathbun JK. Neuropsychological aspects of Wilson disease. Int J Neurosci. 1996;85(3–4):221–9.

    Article  CAS  PubMed  Google Scholar 

  7. Saint-Laurent M. Schizophrenia and Wilson disease. Can J Psychiatr. 1992;37(5):358–60.

    Article  CAS  Google Scholar 

  8. Akil M, Brewer GJ. Psychiatric and behavioral abnormalities in Wilson disease. Adv Neurol. 1995;65:171–8.

    PubMed  CAS  Google Scholar 

  9. Oder W, Grimm G, Kollegger H, Ferenci P, Schneider B, Deecke L. Neurological and neuropsychiatric spectrum of Wilson disease: a prospective study of 45 cases. J Neurol. 1991;238(5):281–7.

    PubMed  CAS  Google Scholar 

  10. Kumawat BL, Sharma CM, Tripathi G, Ralot T, Dixit S. Wilson disease presenting as isolated obsessive-compulsive disorder. Indian J Med Sci. 2007;61(11):607–10.

    Article  CAS  PubMed  Google Scholar 

  11. McDonald LV, Lake CR. Psychosis in an adolescent patient with Wilson disease: effects of chelation therapy. Psychosom Med. 1995;57(2):202–4.

    Article  CAS  PubMed  Google Scholar 

  12. Carr A, McDonnell DJ. Wilson disease in an adolescent displaying an adjustment reaction to a series of life stressors: a case study. J Child Psychol Psychiatry. 1986;27(5):697–700.

    Article  CAS  PubMed  Google Scholar 

  13. Crumley FE. Pitfalls of diagnosis in the early stages of Wilson disease. J Am Acad Child Adolesc Psychiatry. 1990;29(3):470–1.

    Article  CAS  PubMed  Google Scholar 

  14. Srinivas K, Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Janardhana Reddy YC, et al. Dominant psychiatric manifestations in Wilson disease: a diagnostic and therapeutic challenge! J Neurol Sci. 2008;266(1–2):104–8.

    Article  CAS  PubMed  Google Scholar 

  15. Soltanzadeh A, Soltanzadeh P, Nafissi S, Ghorbani A, Sikaroodi H, Lotfi J. Wilson disease: a great masquerader. Eur Neurol. 2007;57(2):80–5.

    Article  PubMed  Google Scholar 

  16. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th world congresses of gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716–21.

    Article  PubMed  Google Scholar 

  17. Frederick RT. Current concepts in the pathophysiology and management of hepatic encephalopathy. Gastroenterol Hepatol (N Y). 2011;7(4):222–33.

    Google Scholar 

  18. Rosenberg R, Renvillard SG, Hjerrild S. Organic delirious states and other psychiatric disorders: lessons for the hepatologists. Metab Brain Dis. 2013;28(2):235–8.

    Article  PubMed  Google Scholar 

  19. Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology. 1998;28(1):45–9.

    Article  CAS  PubMed  Google Scholar 

  20. Siu AL, Bibbins-Domingo K, Grossman DC, Baumann LC, Davidson KW, Ebell M, et al. Screening for depression in adults: US preventive services task force recommendation statement. JAMA. 2016;315(4):380–7.

    Article  CAS  PubMed  Google Scholar 

  21. Patient Health Questionnaire. Available from: http://www.agencymeddirectors.wa.gov/files/AssessmentTools/14- PHQ-9%20overview.pdf

  22. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Lowe B, Unutzer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004;42(12):1194–201.

    Article  PubMed  Google Scholar 

  24. Schaefer M, Gotthardt DN, Ganion N, Wohnsland S, Seessle J, Stremmel W, et al. Wilson disease: health-related quality of life and risk for depression. Clin Res Hepatol Gastroenterol. 2016;40(3):349–56.

    Article  PubMed  Google Scholar 

  25. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.

    Article  PubMed  Google Scholar 

  26. Lowe B, Decker O, Muller S, Brahler E, Schellberg D, Herzog W, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46(3):266–74.

    Article  PubMed  Google Scholar 

  27. Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317–25.

    Article  PubMed  Google Scholar 

  28. Ketter TA. Strategies for monitoring outcomes in patients with bipolar disorder. Prim Care Companion J Clin Psychiatry. 2010;12(Suppl 1):10–6.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Texas Uo. Mood disorder questionnaire. Available from: http://www.dbsalliance.org/pdfs/MDQ.pdf

  30. Prashanth LK, Taly AB, Sinha S, Arunodaya GR, Swamy HS. Wilson disease: diagnostic errors and clinical implications. J Neurol Neurosurg Psychiatry. 2004;75(6):907–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Carta MG, Sorbello O, Moro MF, Bhat KM, Demelia E, Serra A, et al. Bipolar disorders and Wilson disease. BMC Psychiatry. 2012;12:52.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Zimbrean PC, Schilsky ML. The spectrum of psychiatric symptoms in Wilson disease: treatment and prognostic considerations. Am J Psychiatry. 2015;172(11):1068–72.

    Article  PubMed  Google Scholar 

  33. Walshe JM, Yealland M. Wilson disease: the problem of delayed diagnosis. J Neurol Neurosurg Psychiatry. 1992;55(8):692–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Frota NAF, Caramelli P, Barbosa ER. Cognitive impairment in Wilson disease. Dement Neuropsychol. 2009;3(1):16–21.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Wenisch E, De Tassigny A, Trocello JM, Beretti J, Girardot-Tinant N, Woimant F. Cognitive profile in Wilson disease: a case series of 31 patients. Rev Neurol (Paris). 2013;169(12):944–9.

    Article  CAS  Google Scholar 

  36. Riley D, Wiznitzer M, Schwartz S, Zinn AB. A 13-year-old boy with cognitive impairment, retinoblastoma, and Wilson disease. Neurology. 2001;57(1):141–3.

    Article  CAS  PubMed  Google Scholar 

  37. Lauterbach EC, Cummings JL, Duffy J, Coffey CE, Kaufer D, Lovell M, et al. Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington’s, Wilson’s, and Fahr’s diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci. 1998;10(3):249–66.

    Article  CAS  PubMed  Google Scholar 

  38. Sinha S, Christopher R, Arunodaya GR, Prashanth LK, Gopinath G, Swamy HS, et al. Is low serum tocopherol in Wilson disease a significant symptom? J Neurol Sci. 2005;228(2):121–3.

    Article  CAS  PubMed  Google Scholar 

  39. Medalia A, Isaacs-Glaberman K, Scheinberg IH. Neuropsychological impairment in Wilson disease. Arch Neurol. 1988;45(5):502–4.

    Article  CAS  PubMed  Google Scholar 

  40. Isaacs-Glaberman K, Medalia A, Scheinberg IH. Verbal recall and recognition abilities in patients with Wilson disease. Cortex. 1989;25(3):353–61.

    Article  CAS  PubMed  Google Scholar 

  41. Zimbrean PC, Schilsky ML. Psychiatric aspects of Wilson disease: a review. Gen Hosp Psychiatry. 2014;36(1):53–62.

    Article  PubMed  Google Scholar 

  42. Loudianos G, Gitlin JD. Wilson disease. Semin Liver Dis. 2000;20(3):353–64.

    Article  CAS  PubMed  Google Scholar 

  43. Depressive Disorders. Diagnostic and statistical manual of mental disorders: DSM Library: Arlington, VA: American Psychiatric Association. 2013.

    Google Scholar 

  44. Shanmugiah A, Sinha S, Taly AB, Prashanth LK, Tomar M, Arunodaya GR, et al. Psychiatric manifestations in Wilson disease: a cross-sectional analysis. J Neuropsychiatr Clin Neurosci. 2008;20(1):81–5.

    Article  CAS  Google Scholar 

  45. Carta MG, Farina GC, Sorbello O, Moro MF, Cadoni F, Serra A, et al. The risk of bipolar disorders and major depressive disorders in Wilson disease: Results of a case control study. Int Clin Psychopharmacol. 2012;28:e61.

    Article  Google Scholar 

  46. Zimbrean P, Seniow J. Cognitive and psychiatric symptoms in Wilson disease. Handb Clin Neurol. 2017;142:121–40.

    Article  PubMed  Google Scholar 

  47. Dening TR, Berrios GE. Wilson disease: a longitudinal study of psychiatric symptoms. Biol Psychiatry. 1990;28(3):255–65.

    Article  CAS  PubMed  Google Scholar 

  48. Svetel M, Potrebic A, Pekmezovic T, Tomic A, Kresojevic N, Jesic R, et al. Neuropsychiatric aspects of treated Wilson disease. Parkinsonism Relat Disord. 2009;15(10):772–5.

    Article  PubMed  Google Scholar 

  49. Dening TR, Berrios GE. Wilson disease. Psychiatric symptoms in 195 cases. Arch Gen Psychiatry. 1989;46(12):1126–34.

    Article  CAS  PubMed  Google Scholar 

  50. Sagawa M, Takao M, Nogawa S, Mizuno M, Murata M, Amano T, et al. Wilson disease associated with olfactory paranoid syndrome and idiopathic thrombocytopenic purpura. No To Shinkei. 2003;55(10):899–902.

    PubMed  Google Scholar 

  51. Chung YS, Ravi SD, Borge GF. Psychosis in Wilson disease. Psychosomatics. 1986;27(1):65–6.

    Article  CAS  PubMed  Google Scholar 

  52. Shah N, Kumar D. Wilson disease, psychosis, and ECT. Convuls Ther. 1997;13(4):278–9.

    PubMed  CAS  Google Scholar 

  53. Wichowicz HM, Cubala WJ, Slawek J. Wilson disease associated with delusional disorder. Psychiatry Clin Neurosci. 2006;60(6):758–60.

    Article  PubMed  Google Scholar 

  54. Huang CC, Chu NS. Wilson disease: clinical analysis of 71 cases and comparison with previous Chinese series. Journal of the Formosan Medical Association = Taiwan yi zhi. 1992;91(5):502–7.

    PubMed  CAS  Google Scholar 

  55. Practice guideline for the assessment and treatment of patients with suicidal behaviors. Am J Psychiatry. 2003;160(11 Suppl):1–60.

    Google Scholar 

  56. Dening TR, Berrios GE. Wilson disease: a prospective study of psychopathology in 31 cases. Br J Psychiatry. 1989;155:206–13.

    Article  CAS  PubMed  Google Scholar 

  57. Freudenreich O, Holt DJ, Cather C, Goff DC. The evaluation and management of patients with first-episode schizophrenia: a selective, clinical review of diagnosis, treatment, and prognosis. Harv Rev Psychiatry. 2007;15(5):189–211.

    Article  PubMed  Google Scholar 

  58. EASL Clinical Practice Guidelines. Wilson disease. J Hepatol. 2012;56(3):671–85.

    Article  Google Scholar 

  59. Cox DW. A screening test for Wilson disease and its application to psychiatric patients. Can Med Assoc J. 1967;96(2):83–6.

    PubMed  PubMed Central  CAS  Google Scholar 

  60. Gedack M, Schönfeldt-Lecuona C, Kratzer W, Kassubek J, Connemann B. P03-538 – ceruloplasmin serum concentrations in a randomized population sample of 2,445 subjects. Eur Psychiatry. 2011;26:1708.

    Article  Google Scholar 

  61. Demily C, Parant F, Cheillan D, Broussolle E, Pavec A, Guillaud O, et al. Screening of Wilson disease in a psychiatric population: difficulties and pitfalls. A preliminary study. Ann General Psychiatry. 2017;16:19.

    Article  Google Scholar 

  62. Brewer GJ. Wilson disease. In: Frucht SJFS, editor. Movement disorder emergencies: diagnosis and treatment. Totowa: Humana Press; 2007. p. 195–208.

    Google Scholar 

  63. Finelli PF. Kayser-Fleischer ring: hepatolenticular degeneration (Wilson disease). Neurology. 1995;45(7):1261–2.

    Article  CAS  PubMed  Google Scholar 

  64. Youn J, Kim JS, Kim HT, Lee JY, Lee PH, Ki CS, et al. Characteristics of neurological Wilson disease without Kayser-Fleischer ring. J Neurol Sci. 2012;323(1–2):183–6.

    Article  PubMed  Google Scholar 

  65. Herring NR, Konradi C. Myelin, copper, and the cuprizone model of schizophrenia. Front Biosci (Schol Ed). 2011;3:23–40.

    Google Scholar 

  66. Gonzalez-Estecha M, Trasobares EM, Tajima K, Cano S, Fernandez C, Lopez JL, et al. Trace elements in bipolar disorder. J Trace Elem Med Biol. 2011;25(Suppl 1):S78–83.

    Article  CAS  PubMed  Google Scholar 

  67. Bachmann H, Lossner J, Kuhn HJ, Biesold D, Siegemund R, Kunath B, et al. Long-term care and management of Wilson disease in the GDR. Eur Neurol. 1989;29(6):301–5.

    Article  CAS  PubMed  Google Scholar 

  68. Modai I, Karp L, Liberman UA, Munitz H. Penicillamine therapy for schizophreniform psychosis in Wilson disease. J Nerv Ment Dis. 1985;173(11):698–701.

    Article  CAS  PubMed  Google Scholar 

  69. Krim E, Barroso B. Psychiatric disorders treated with clozapine in a patient with Wilson disease. Presse Med. 2001;30(15):738.

    PubMed  CAS  Google Scholar 

  70. Kulaksizoglu IB, Polat A. Quetiapine for mania with Wilson disease. Psychosomatics. 2003;44(5):438–9.

    Article  PubMed  Google Scholar 

  71. Kontaxakis V, Stefanis C, Markidis M, Tserpe V. Neuroleptic malignant syndrome in a patient with Wilson disease. J Neurol Neurosurg Psychiatry. 1988;51(7):1001–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Chroni E, Lekka NP, Tsibri E, Economou A, Paschalis C. Acute, progressive akinetic-rigid syndrome induced by neuroleptics in a case of Wilson disease. J Neuropsychiatry Clin Neurosci. 2001;13(4):531–2.

    Article  CAS  PubMed  Google Scholar 

  73. Bleakley S. Identifying and reducing the risk of antipsychotic drug interactions. Prog Neurol Psychiatry. 2012;16(2):20–4.

    Article  Google Scholar 

  74. Woerwag-Mehta S, Hindley P, Hedderly T, Dhawan A. Complex psychiatric presentation in adolescent onset Wilson disease. BMJ Case Rep. 2011;2011 http//casereports.bmj.com/content/2011/bcr.01.2010.2628.full.pdf

    Google Scholar 

  75. Loganathan S, Nayak R, Sinha S, Taly AB, Math S, Varghese M. Treating mania in Wilson disease with lithium. J Neuropsychiatry Clin Neurosci. 2008;20(4):487–9.

    Article  PubMed  Google Scholar 

  76. Vaishnav P, Gandhi HA. Electro Convulsive Therapy in Psychiatric Manifestations in Wilson disease. Indian J Psychol Med. 2013;35(2):206–8.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Walter G, Lyndon B. Depression in hepatolenticular degeneration (Wilson disease). Aust N Z J Psychiatry. 1997;31(6):880–2.

    Article  CAS  PubMed  Google Scholar 

  78. Gill HH, Shankaran K, Desai HG. Wilson disease: varied hepatic presentations. Indian J Gastroenterol. 1994;13(3):95–8.

    PubMed  CAS  Google Scholar 

  79. Knott A, Dieperink E, Willenbring ML, Heit S, Durfee JM, Wingert M, et al. Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes. Am J Gastroenterol. 2006;101(10):2254–62.

    Article  PubMed  Google Scholar 

  80. Minden SL, Ding L, Cleary PD, Frankel D, Glanz BI, Healy BC, et al. Improving the quality of mental health care in multiple sclerosis. J Neurol Sci. 2013;335(1–2):42–7.

    Article  CAS  PubMed  Google Scholar 

  81. Wilson Disease Centers of Excellence. Available from: https://www.wilsonsdisease.org/for-patients-families/centers-of-excellence

  82. Sorbello O, Riccio D, Sini M, Carta M, Demelia L. Resolved Psychosis after liver transplantation in a patient with Wilson disease. Clin Pract Epidemiol Ment Health. 2011;7:182–4.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Lankarani KB, Malek-Hosseini SA, Nikeghbalian S, Dehghani M, Pourhashemi M, Kazemi K, et al. Fourteen years of experience of liver transplantation for Wilson disease; a report on 107 cases from Shiraz, Iran. PLoS One. 2016;11(12):e0167890.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Al-Hilou H, Hebbar S, Gunson BK, Claridge LC, Syn WK, Holt AP. Long term outcomes of liver transplantation for Wilson disease: a single centre experience. Gut. 2012;61:A210.

    Article  Google Scholar 

  85. Geissler I, Heinemann K, Rohm S, Hauss J, Lamesch P. Liver transplantation for hepatic and neurological Wilson disease. Transplant Proc. 2003;35(4):1445–6.

    Article  CAS  PubMed  Google Scholar 

  86. Stracciari A, Tempestini A, Borghi A, Guarino M. Effect of liver transplantation on neurological manifestations in Wilson disease. Arch Neurol. 2000;57(3):384–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paula C. Zimbrean .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Munjal, S., Zimbrean, P.C. (2018). Psychiatric Aspects of Wilson Disease. In: Schilsky, M. (eds) Management of Wilson Disease . Clinical Gastroenterology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-91527-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-91527-2_7

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-91526-5

  • Online ISBN: 978-3-319-91527-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics